Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company aims for the Registration Statement to be declared effective by 5:00 p.m. Eastern time on February 1, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David Wolpa, attorneys from Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the effectiveness of the Registration Statement orally with its legal representatives upon declaration.

Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company aims for the Registration Statement to be declared effective by 5:00 p.m. Eastern time on February 1, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David Wolpa, attorneys from Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the effectiveness of the Registration Statement orally with its legal representatives upon declaration.